TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,113,000 | +17.1% | 2,215,000 | +10.8% | 0.12% | -3.3% |
| Q4 2018 | $1,805,000 | -52.0% | 2,000,000 | -50.0% | 0.12% | -24.4% |
| Q3 2018 | $3,762,000 | -54.9% | 4,000,000 | -55.6% | 0.16% | -59.0% |
| Q2 2018 | $8,333,000 | -6.9% | 9,000,000 | -11.3% | 0.39% | -12.4% |
| Q1 2018 | $8,946,000 | -3.2% | 10,150,000 | -2.9% | 0.44% | -2.0% |
| Q4 2017 | $9,240,000 | +86.1% | 10,450,000 | +90.0% | 0.45% | +86.8% |
| Q3 2017 | $4,964,000 | -72.0% | 5,500,000 | -63.0% | 0.24% | -71.7% |
| Q3 2016 | $17,728,000 | +37.7% | 14,850,000 | +44.9% | 0.86% | -0.3% |
| Q2 2016 | $12,874,000 | -35.2% | 10,250,000 | -32.8% | 0.86% | -29.5% |
| Q1 2016 | $19,866,000 | +237.1% | 15,250,000 | +306.7% | 1.22% | +248.9% |
| Q4 2015 | $5,893,000 | – | 3,750,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 20,000,000 | $17,675,000 | 25.38% |
| INCOME RESEARCH & MANAGEMENT | 23,109,000 | $20,278,000 | 5.29% |
| Fore Capital, LLC | 5,000,000 | $4,430,000 | 1.71% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 20,000,000 | $17,603,000 | 0.74% |
| ARISTEIA CAPITAL, L.L.C. | 18,500,000 | $16,361,000 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 11,153,000 | $9,843,000 | 0.58% |
| BASSO CAPITAL MANAGEMENT, L.P. | 3,600,000 | $3,182,000 | 0.52% |
| CSS LLC/IL | 10,450,000 | $9,240,000 | 0.45% |
| Lombard Odier Asset Management (Europe) Ltd | 7,950,000 | $7,038,000 | 0.44% |
| Wellesley Asset Management | 6,740 | $5,948,000 | 0.31% |